Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 15 versus OSMITROL 10 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 15 versus OSMITROL 10 IN WATER.
MANNITOL 15% vs OSMITROL 10% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Increases plasma osmolality, drawing water from intracellular and interstitial spaces into the vascular compartment, thereby reducing intracranial pressure and intraocular pressure. Acts as an osmotic diuretic in the kidneys, increasing urine flow by inhibiting water reabsorption in the proximal tubule and loop of Henle.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
1-2 g/kg as a 15% solution intravenously over 30-60 minutes. Typical adult dose: 100-200 g (667-1333 mL of 15% solution) administered as a single dose for reduction of intracranial pressure or promotion of diuresis.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
None Documented
None Documented
Terminal elimination half-life approximately 0.25-1.5 hours in normal renal function; prolonged to 24-36 hours in renal impairment.
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Primarily renal (90-100% as unchanged drug); negligible biliary/fecal elimination.
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic